Tasly Pharmaceutical Group Co., Ltd

This study tests whether injecting stem cells from donated umbilical cords into the heart muscle during bypass surgery can help people with chronic heart failure. About 51 adults with weak hearts (ejection fraction 40% or less) will receive the stem cells or a placebo. The goal i…

This study tests a single injection of stem cells (B2065) given within 36 hours of a stroke. About 54 adults aged 18-75 with moderate-to-severe stroke will receive either the stem cells or a placebo. The main goals are to check safety and see if the treatment helps improve recove…

This early-phase trial tests a new oral drug, TSL2109, in people with advanced solid tumors, especially prostate and breast cancers that have stopped responding to standard treatments. The drug targets two proteins to block cancer growth and overcome resistance. The main goals ar…

This study tests a new treatment called P134 cells, which are specially engineered immune cells (CAR-T cells) designed to target and attack recurrent glioblastoma, a severe type of brain cancer. The trial involves 26 adults whose cancer has returned and who have a specific marker…

This study tests if Lianxiaxiaopi Granules, a traditional Chinese medicine, can reduce stomach discomfort after meals (like fullness and feeling full too quickly). About 342 adults with this condition will receive either the granules or a placebo. The goal is to see if the granul…